Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib
Journal article published in 2022 by
Noelia Purroy,
Yuzhou Evelyn Tong,
Camilla K. Lemvigh 
,
Nicoletta Cieri ,
Shuqiang Li,
Erin M. Parry ,
Wandi Zhang,
Laura Z. Rassenti,
Thomas J. Kipps,
Susan L. Slager,
Neil E. Kay ,
Connie Lesnick,
Tait D. Shanafelt,
Paolo Ghia ,
Lydia Scarfò
and other authors.
,
Nicoletta Cieri ,
Shuqiang Li,
Erin M. Parry ,
Wandi Zhang,
Laura Z. Rassenti,
Thomas J. Kipps,
Susan L. Slager,
Neil E. Kay ,
Connie Lesnick,
Tait D. Shanafelt,
Paolo Ghia ,
Lydia Scarfò
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 